Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Issam Raad

9PUBLICATIONS

16CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Microbial ecologyMedical bacteriologyWastewater treatment processes

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Apr 20, 2026

Antimicrobial elution patterns correlate with antibacterial and antifungal activities of three antimicrobial central venous catheters in serum.

|Aug 02, 2024

A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia.

Anne-Marie Chaftari, Hiba Dagher, Ray Hachem

|Apr 11, 2024

<i>In vitro</i> activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer.

Bahgat Gerges, Joel Rosenblatt, Y-Lan Truong

|Dec 13, 2023

<i>In vitro</i> activity of tebipenem and comparator agents against bacterial pathogens isolated from patients with cancer.

Bahgat Gerges, Joel Rosenblatt, Samuel A Shellburne

|Mar 06, 2023

<i>In vitro</i> activity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancer.

Kenneth Rolston, Bahgat Gerges, Lior Nesher

|Jun 06, 2022

A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies.

Anne-Marie Chaftari, Ray Hachem, Alexandre E Malek

Pageof 2

Frequent Collaborators

4 joint publications

Bahgat Z Gerges

3 joint publications

Samuel A Shellburne

2 joint publications

Joel Rosenblatt

2 joint publications

Y-Lan Truong

2 joint publications

Ying Yuan

2 joint publications

Ray Hachem

1 joint publications

Teny John

1 joint publications

Elizabeth Frenzel

1 joint publications

Georgia Thomas

1 joint publications

Fareed Khawaja

Frequent Collaborators

4 joint publications

Bahgat Z Gerges

3 joint publications

Samuel A Shellburne

2 joint publications

Joel Rosenblatt

2 joint publications

Y-Lan Truong

Top Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on : Mar 03, 2023

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or <em>A. baumannii</em>

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or <em>A. baumannii</em>

Published on : Jan 02, 2017

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on : Oct 25, 2024

See more related videos

Top Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on : Mar 03, 2023

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or <em>A. baumannii</em>

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or <em>A. baumannii</em>

Published on : Jan 02, 2017

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on : Oct 25, 2024

See more related videos